Electromed, Inc.

ELMD ·Healthcare, Medical Devices, United States
Financial Statements Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2018 FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011
Operating Activities
Net Income $1.8M $2.2M $2.2M $1.1M $-1.3M $-1.3M $186.6K $1.1M
Depreciation & Amortization
Depreciation $676.4K $636.7K $616.0K $613.3K $567.3K $459.8K $408.6K $335.6K
Amortization $113.6K $118.4K $122.7K $122.9K $128.2K $130.0K $124.0K $113.9K
Stock-Based Compensation $862.7K $479.5K $222.8K $110.4K $82.2K $175.8K $135.6K $156.2K
Net Cash from Operating Activities $2.4M $1.2M $2.2M $2.8M $2.1M $1.9M $-1.2M $-1.4M
Investing Activities
Capital Expenditures $526.2K $618.8K $534.9K $523.2K $895.2K $1.0M $791.6K $466.3K
Business Acquisitions
Net Cash from Investing Activities $-571.8K $-687.1K $-579.5K $-848.8K $-1.1M
Financing Activities
Dividends Paid
Stock Repurchases
Net Cash from Financing Activities $11.7K $-53.6K $-62.3K $-61.2K $-368.8K $6.0M
Net Change in Cash $2.1M $999.1K $-1.2M $-2.4M $3.5M
Free Cash Flow $1.9M $572.4K $1.6M $2.3M $1.2M $860.0K $-2.0M $-1.9M
← Newer Page 2 of 2 Older →